John Alexander Kelly - 02 Jun 2025 Form 4 Insider Report for PRECISION BIOSCIENCES INC (DTIL)

Role: Chief Financial Officer
Signature: /s/ Dario Scimeca Attorney-in-fact for Alex Kelly
Issuer symbol: DTIL
Transactions as of: 02 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2025, 17:00:36 UTC
Previous filing: 05 Mar 2025
Next filing: 08 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Kelly John Alexander	Chief Financial Officer	C/O PRECISION BIOSCIENCES, INC., 302 E. PETTIGREW STREET, SUITE A-100, DURHAM	/s/ Dario Scimeca Attorney-in-fact for Alex Kelly	04 Jun 2025	0001590030

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	DTIL	Restricted Stock Units	Award	$0	+82,750		$0.000000	82,750	02 Jun 2025	Common Stock	82,750		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock.
F2	Award vests in three substantially equal annual installments beginning on February 17, 2026, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.